The estimated Net Worth of Jenniffer Collins is at least $3.27 ezer dollars as of 8 November 2017. Jenniffer Collins owns over 7,000 units of Teligent Inc stock worth over $3,265 and over the last 9 years Jenniffer sold TLGT stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jenniffer Collins TLGT stock SEC Form 4 insiders trading
Jenniffer has made over 1 trades of the Teligent Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Jenniffer bought 7,000 units of TLGT stock worth $21,280 on 8 November 2017.
The largest trade Jenniffer's ever made was buying 7,000 units of Teligent Inc stock on 8 November 2017 worth over $21,280. On average, Jenniffer trades about 2,333 units every 0 days since 2016. As of 8 November 2017 Jenniffer still owns at least 19,206 units of Teligent Inc stock.
You can see the complete history of Jenniffer Collins stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Jenniffer Collins's mailing address?
Jenniffer's mailing address filed with the SEC is C/O TELIGENT, INC., 105 LINCOLN AVENUE, BUENA, NJ, 08310.
Insiders trading at Teligent Inc
Over the last 9 years, insiders at Teligent Inc have traded over $1,419,503 worth of Teligent Inc stock and bought 245,910 units worth $400,963 . The most active insiders traders include James C Gale, Sciences Opportunities Fund... és John E Celentano. On average, Teligent Inc executives and independent directors trade stock every 89 days with the average trade being worth of $8,816. The most recent stock trade was executed by Philip K Yachmetz on 16 July 2021, trading 7,835 units of TLGT stock currently worth $1,332.
What does Teligent Inc do?
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market.
What does Teligent Inc's logo look like?
Complete history of Jenniffer Collins stock trades at Teligent Inc
Teligent Inc executives and stock owners
Teligent Inc executives and other stock owners filed with the SEC include:
-
John Celentano,
Chairman of the Board -
Steven Koehler,
Independent Director -
Bhaskar Chaudhuri,
Independent Director -
Carole Ben-Maimon,
Independent Director -
Thomas Sabatino,
Independent Director -
Philip Yachmetz,
Chief Legal Officer, Corporate Secretary -
Timothy Sawyer,
President, Chief Executive Officer, Director -
Martin Wilson,
General Counsel -
Stephen Richardson,
Chief Scientific Officer -
Jenniffer Collins,
CFO -
Narendra N Borkar,
Director -
Sciences Opportunities Fund...,
-
James C Gale,
Director -
Jason Grenfell Gardner,
President & CEO -
Damian Finio,
CFO -
Paolantonio Ernest Robert De,
Chief Financial Officer -
William S Marth,
Director -
R Carter Pate,
Director